FLEX vs PLXS: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: FLEX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. FLEX and PLXS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined FLEX and PLXS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Flex Ltd is a global electronics manufacturing services (EMS) company, effectively an outsourced factory and supply chain that designs and builds products for other brands. It is consistently ranked among the largest EMS providers in the world by revenue, competing near the top of the industry with fiscal-year revenue in the mid-$20 billions. Flex reports across segments including Flex Agility Solutions and Flex Reliability Solutions, serving end markets that span cloud and data-center infrastructure, automotive, industrial, healthcare, and energy. Because it manufactures on contract, its margins are structurally thin compared with the brands it serves, and the investment case turns on volume, efficiency, and moving into higher-value services like design, power products, and data-center integration.

Full FLEX guide

Plexus Corp (NASDAQ: PLXS), headquartered in Neenah, Wisconsin and operating since 1979, is a contract electronics manufacturer that provides integrated lifecycle solutions spanning design and development, supply chain, new product introduction, manufacturing, and aftermarket services. Unlike the scale-driven giants of the EMS industry, Plexus deliberately targets mid-to-low volume, higher-complexity programs in three regulated sectors: Aerospace/Defense, Healthcare/Life Sciences, and Industrial. Its work includes life-saving medical devices, mission-critical defense electronics, industrial automation, and semiconductor capital equipment, where certifications, traceability, and engineering rigor matter more than raw volume economics.

Full PLXS guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• FLEX drivers: Data-center and AI infrastructure demand; Margin-mix shift toward higher-value work.
• PLXS drivers: Regulated-market specialization; Program ramps and revenue momentum.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The dominant risk is that EMS is a low-margin, high-volume business, so thin margins leave little room for error and any operational stumble or pricing pressure hits profit quickly. For PLXS, the most cited risk is valuation: the stock has roughly doubled in a year and trades at a premium price-to-earnings multiple, creating meaningful downside if growth or margins disappoint.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick FLEX if you believe its drivers more; PLXS if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the FLEX and PLXS guides.

FLEX. Figures are approximate and tied to the asOf date; verify live numbers before acting. For a contract manufacturer, revenue is large but margins are thin, so profit and free cash flow matter more than headline sales, and the valuation debate centers on whether the mix shift into data-center and higher-margin work justifies a higher multiple than a traditional low-margin EMS name. Comparisons to peers like Jabil and Celestica on forward earnings and margin trajectory are usually more informative than an absolute multiple.

PLXS. Plexus generates roughly $4.1 billion in trailing revenue and around $173 million in net income, with fiscal Q2 2026 setting a quarterly revenue record near $1.16 billion. The stock has roughly doubled over the prior year, lifting its trailing P/E into the mid-to-high 30s and its forward P/E to the high 20s to low 30s. That places it at a premium to its own history and richer than several EMS peers, reflecting optimism about margin expansion that has already been partly priced in.

Headline figures (approximate, Jul 2026): FLEX shows revenue Recent quarterly revenue in the high-$6 billion range; annual revenue in the mid-$20 billions (approximate; verify live), earnings trend Has beaten adjusted EPS estimates in most recent quarters, helped by data-center demand, margins Structurally thin EMS gross margins (roughly high single digits); operating margin is the key improvement metric, market cap Roughly low-to-mid $20 billions (approximate; verify live); PLXS shows revenue (ttm) ~$4.1B, net income (ttm) ~$173M, fiscal q2 2026 revenue ~$1.16B (record), fiscal q2 2026 non-gaap eps ~$2.05.

FLEX and PLXS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined FLEX and PLXS exposure against your real portfolio. It is not an investment adviser.